Using the PRIME Type 2 Diabetes Product and info in the SURPASS-two trial, this review evaluated the extended-time period cost-efficiency of assorted doses of tirzepatide in opposition to semaglutide from the US healthcare payer point of view. Tirzepatide is at this time sold under the brand name Mounjaro, and https://jacquesq765crh2.mysticwiki.com/user